Work

DYRK1A Is a Therapeutic Target in B-ALL in Children with Down Syndrome

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.2721.2721

Authors: Paul Lee, Rahul Bhansali, Malini Rammohan, Nobuko Hijiya, Shai Izraeli, Jean-Pierre Bourquin, Sebastien Malinge, John Crispino

Institutions: Lurie Children's Hospital, Northwestern University, Tel Aviv University, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, University Children's Hospital Zurich, Inserm, Institut Gustave Roussy

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2744535833

FWCI:

Cites:

Cited by:

Related to: 10